IL6 and stroke disorder: When mice were treated with ibrutinib or PBS on day 0, mature IL-1β protein levels on day 1 after stroke onset were much lower in the brain lysates of ibrutinib-treated mice than in control mice, whereas the IL-6 and TNF-α protein levels were similar (Fig. 3f).